English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18033/20233 (89%)
造訪人次 : 23238838      線上人數 : 456
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/1082


    標題: Investigation of hydrogel nanoparticles delivery systems for anti-obesity drug
    減肥藥物之凝膠型耐米微粒藥物輸移系統
    作者: 林恆弘
    貢獻者: 藥學系
    關鍵字: 水不溶
    奈米微粒
    親水膠體
    phenylpropanolamine
    Water-insoluble
    Nanoparticles
    Hydrogel
    日期: 2003
    上傳時間: 2008-06-26 10:40:00 (UTC+8)
    出版者: 台南縣:嘉南藥理科技大學藥學系
    摘要: Suspensions composed of numberless nanoparticles were used for improved solubilization of phenylpropanolamine (PPA). Nanoparticles encapsulating PPA HCl were prepared using the solid jelly pulverization technique. The size of the PPA HCl - hydrogel nanoparticles was assessed using a LS particle size analyzer and scanning electron microscopy(SEM). The rheological properties of suspensions are characterized by Cone and Plate Viscometer. In addition, any drug-polymer interactions were assessed using a differential scanning calorimeter (DSC). The results show that solid jelly pulverization technique yielded PPA HCl hydrogel nanoparticles with a mean diameter of 40 nm to 800 nm. Based on our release profiles, following an initial burst release of 40% to 50% PPA HCl, the release was sustained over the 24-hours study period. Moreover, while pH value of PPA HCl – loaded nanoparticles suspension increased over 3, no significant agglomeration of insoluble drug were grown. The DSC measurements indicated that the chemical interaction does not occur among the components during manufacturing processes and reconstituting lyophilized powder. The above results will be helpful to possible development of the other water-insoluble drug delivery systems.
    本研究採用含無數奈米微粒之懸液來改善難溶性藥物phenylpropanolamine (PPA)之溶解度。奈米微粒包覆PPA HCl是以固態凝膠研磨技術來完成,負載PPA HCl之親水膠體奈米微粒以雷射粒徑分析儀與掃瞄式電子顯微鏡來檢測其粒子大小,懸液之流體特性是以Cone and Plate黏度計來評估,此外,藥物與膠體聚合物間之交互作用則是以熱卡式分析儀來檢視。結果顯示,以固態凝膠研磨技術所獲得的PPA HCl親水膠體奈米微粒其平均粒徑是介於40到800奈米之間,基於體外藥物釋離圖形,PPA HCl於最初突釋40%至50%後,其釋離可維持24小時的持續釋放,而且,當負載藥物奈米微粒之懸液其酸鹼值上揚超過3時,也未有不溶性藥物明確的凝結物生成;經由熱分析的觀察得知,不論是製造或是凍晶乾燥粉體加水還原之過程,各組成分間均未有明顯的化學交互作用發生。綜合上述之實驗結果,將有助於協助發展其他難溶性藥物之輸移系統。
    關聯: 計畫編號:CNPH9206
    顯示於類別:[藥學系(所)] 校內計畫

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    92CNPH9206.pdf202KbAdobe PDF1112檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋